These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 7544983

  • 21. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.
    Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P.
    Transplantation; 1994 Jul 27; 58(2):170-8. PubMed ID: 7518975
    [Abstract] [Full Text] [Related]

  • 22. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.
    Liver Transpl; 2008 Feb 27; 14(2):173-80. PubMed ID: 18236391
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK, Montagnino G, Del Castillo D, Margreiter R, Sperschneider H, Olbricht CJ, Krüger B, Ortuño J, Köhler H, Kunzendorf U, Stummvoll HK, Tabernero JM, Mühlbacher F, Rivero M, Arias M, European Tacrolimus vs Cyclosporin Microemulsion Renal Transplantation Study Group.
    Nephrol Dial Transplant; 2005 May 27; 20(5):968-73. PubMed ID: 15741208
    [Abstract] [Full Text] [Related]

  • 24. Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
    Ott R, Bussenius-Kammerer M, Reck T, Koch CA, Kissler H, Hohenberger W, Müller V.
    Transpl Int; 2004 Jan 27; 17(1):39-43. PubMed ID: 14504723
    [Abstract] [Full Text] [Related]

  • 25. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO, Ehlermann P, Koch A, Remppis A, Katus HA, Dengler TJ.
    Clin Ther; 2006 Jun 27; 28(6):893-905. PubMed ID: 16860172
    [Abstract] [Full Text] [Related]

  • 26. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P.
    Transpl Int; 2001 Dec 27; 14(6):420-8. PubMed ID: 11793040
    [Abstract] [Full Text] [Related]

  • 27. Nicardipine as antihypertensive therapy in liver transplant recipients: results of long-term use.
    Duvoux C, Cherqui D, Di Martino V, Métreau JM, Salvat A, Lauzet JY, Fagniez PL, Dhumeaux D.
    Hepatology; 1997 Feb 27; 25(2):430-3. PubMed ID: 9021959
    [Abstract] [Full Text] [Related]

  • 28. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
    Taler SJ, Textor SC, Canzanello VJ, Schwartz L, Porayko M, Wiesner RH, Krom RA.
    Transplantation; 1996 Dec 15; 62(11):1588-92. PubMed ID: 8970613
    [Abstract] [Full Text] [Related]

  • 29. Impact of pretransplant renal function on survival after liver transplantation.
    Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS.
    Transplantation; 1995 Feb 15; 59(3):361-5. PubMed ID: 7871566
    [Abstract] [Full Text] [Related]

  • 30. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P, Lilly L, Scudamore C, Erb S, Yoshida E, Kneteman N, Bain V, Ghent C, Marotta P, Grant D, Wall W, Tchervenkov J, Barkun J, Roy A, Marleau D, McAlister V, Peltekian K.
    Liver Transpl; 2003 Jun 15; 9(6):587-95. PubMed ID: 12783400
    [Abstract] [Full Text] [Related]

  • 31. Non-lymphoid cancer after liver transplantation.
    Frezza EE, Fung JJ, van Thiel DH.
    Hepatogastroenterology; 1997 Jun 15; 44(16):1172-81. PubMed ID: 9261620
    [Abstract] [Full Text] [Related]

  • 32. Improved classification of dippers by individualized analysis of ambulatory blood pressure profiles.
    Gatzka CD, Schmieder RE.
    Am J Hypertens; 1995 Jul 15; 8(7):666-71. PubMed ID: 7546489
    [Abstract] [Full Text] [Related]

  • 33. Experience of FK506 immune suppression in pediatric heart transplantation: a study of long-term adverse effects.
    Asante-Korang A, Boyle GJ, Webber SA, Miller SA, Fricker FJ.
    J Heart Lung Transplant; 1996 Apr 15; 15(4):415-22. PubMed ID: 8732602
    [Abstract] [Full Text] [Related]

  • 34. Reduced incidence of hypertension after heterotopic cardiac transplantation compared with orthotopic cardiac transplantation: evidence that excision of the native heart contributes to post-transplant hypertension.
    Taegtmeyer AB, Crook AM, Barton PJ, Banner NR.
    J Am Coll Cardiol; 2004 Sep 15; 44(6):1254-60. PubMed ID: 15364328
    [Abstract] [Full Text] [Related]

  • 35. An improved glomerular filtration rate in cardiac transplant recipients with once-a-day cyclosporine dosing.
    Bunke M, Sloan R, Brier M, Ganzel B.
    Transplantation; 1995 Feb 27; 59(4):537-40. PubMed ID: 7878758
    [Abstract] [Full Text] [Related]

  • 36. [Circadian behavior of blood pressure and heart rate following orthotopic heart transplantation. Studies before and during antihypertensive therapy].
    Angermann CE, Spes CH, Willems S, Dominiak P, Kemkes BM, Theisen K.
    Z Kardiol; 1989 Apr 27; 78(4):228-35. PubMed ID: 2544062
    [Abstract] [Full Text] [Related]

  • 37. Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients.
    Kovarik JM, Villamil F, Otero A, Levy G, Lynch S, Cillo U, Fischer L, Nashan B, Pollard S, De Carlis L.
    Clin Transplant; 2008 Apr 27; 22(1):68-75. PubMed ID: 18217908
    [Abstract] [Full Text] [Related]

  • 38. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus].
    Peng LK, Xie XB, Peng FH, Wang Y, Jiang Y, Lan GB, Fang CH, Nie MH.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb 27; 32(1):59-62. PubMed ID: 17344588
    [Abstract] [Full Text] [Related]

  • 39. Diabetes mellitus and islet cell specific autoimmunity as adverse effects of immunsuppressive therapy by FK506/tacrolimus.
    Lohmann T, List C, Lamesch P, Kohlhaw K, Wenzke M, Schwarz C, Richter O, Hauss J, Seissler J.
    Exp Clin Endocrinol Diabetes; 2000 Feb 27; 108(5):347-52. PubMed ID: 10989953
    [Abstract] [Full Text] [Related]

  • 40. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients.
    Textor SC, Wiesner R, Wilson DJ, Porayko M, Romero JC, Burnett JC, Gores G, Hay E, Dickson ER, Krom RA.
    Transplantation; 1993 Jun 27; 55(6):1332-9. PubMed ID: 7685934
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.